Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 30.83M P/E - EPS this Y 11.60% Ern Qtrly Grth -
Income -40.33M Forward P/E -1.01 EPS next Y 46.20% 50D Avg Chg -13.00%
Sales - PEG 0.02 EPS past 5Y - 200D Avg Chg -40.00%
Dividend N/A Price/Book 0.25 EPS next 5Y -65.60% 52W High Chg -65.00%
Recommedations 1.70 Quick Ratio 13.12 Shares Outstanding 24.81M 52W Low Chg 10.00%
Insider Own 5.43% ROA -29.56% Shares Float 18.02M Beta 0.93
Inst Own 38.75% ROE -48.12% Shares Shorted/Prior 31.13K/36.36K Price 1.37
Gross Margin - Profit Margin - Avg. Volume 137,261 Target Price 15.60
Oper. Margin - Earnings Date May 9 Volume 100,990 Change 5.38%
About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for kidney transplantation, xenotransplantation, and liver transplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Eledon Pharmaceuticals, Inc. News
03/28/24 Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
03/25/24 Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
03/21/24 Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
02/13/24 Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/04/24 Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
12/25/23 Will Eledon Pharmaceuticals (NASDAQ:ELDN) Spend Its Cash Wisely?
11/29/23 Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
11/09/23 Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
11/08/23 Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
11/02/23 Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
10/23/23 Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
10/13/23 Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting
10/02/23 Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors
09/25/23 Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human
09/20/23 Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
09/06/23 Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates
06:00 AM Eledon Pharmaceuticals Announces First Participant Dosed in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Rejection in Kidney Transplantation
08/16/23 Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation
08/10/23 Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results
07/12/23 Amerigo Reports Q2-2023 Production Results and Provides MVC Operational Update
ELDN Chatroom

User Image Kanate123 Posted - 04/30/24

$ELDN love eldn but also LOVE: ESPR Esperion Possible Takeover Price Prediction Bullish Target Date Dec 20 Target Price $12.72 Current Price $1.99 Starting Price $2.00 Since Prediction $0.015 (0.75%) Hide Details Start Date Apr 30, 2024 10:23 AM EST Target Date Dec 20, 2024 4:00 PM EST Create Your Prediction

User Image Stocks4thought Posted - 04/30/24

$INDP Big Meck and biggie on this. ot $MAIA $SLNO $ELDN $STTK

User Image Stocks4thought Posted - 04/30/24

$MAIA ot $MRKR $ELDN $SLNO

User Image PlannedTrading101 Posted - 04/30/24

$ELDN ?

User Image Stocks4thought Posted - 04/29/24

$ELDN looking for .70 cent move

User Image Kanate123 Posted - 04/29/24

$ELDN keep an eye on ESPR this drug stock is ready to runn

User Image RallyRaider Posted - 04/29/24

$ELDN nice breakout on volume, tackled seller

User Image Stocks4thought Posted - 04/29/24

$ELDN Can you say break out?

User Image Stocks4thought Posted - 04/29/24

$MAIA Other fireworks $SLNO $MRKR SOON $ELDN partials 04/14/2023 10:03:18 Bought 1200 SLNO @ 3.7499 -4,499.88 0.00 0.00 04/14/2023 10:03:18 Bought 800 SLNO @ 3.7287

User Image Ontherag Posted - 04/26/24

$ELDN Added, nice little company we got here, interim clinical ph1b update June

User Image Stocks4thought Posted - 04/24/24

$ELDN Half the story is in the volume Apr 22, 2024 2.0000 2.2000 1.9200 2.0200 2.0200 313,600 Apr 19, 2024 2.1100 2.1830 1.7700 1.8600 1.8600 420,300 Apr 18, 2024 1.5500 2.0000 1.5500 1.9900 1.9900 400,100

User Image Stocks4thought Posted - 04/24/24

$ELDN Looking for an explosion over $2.21........ot $SLNO $IMMP

User Image Stocks4thought Posted - 04/23/24

$ELDN https://www.aol.com/pig-kidney-transplant-patient-leaves-024452908.html

User Image Lovethespace27 Posted - 04/23/24

$ELDN

User Image Stocks4thought Posted - 04/22/24

$ELDN $2.37 soon

User Image Stocks4thought Posted - 04/19/24

$ELDN Sheethole pumpers got this early. See posts below.

User Image Fullratio Posted - 04/19/24

$ELDN debt is 100% smaller than its equity: https://fullratio.com/stocks/nasdaq-eldn/eledon-pharmaceuticals

User Image HScottMatusow Posted - 04/18/24

@threethrees Please read our articles. Last one is about $GLYC on Seeking Alpha. We don't pump stocks, we are not paid. "Alert" from us means we think a stock will run. I gave the "alert" when the stock was $1.82. Please review our account here - u won't find a handful of "alerts" because generally, we are too busy trading. We been watching $ELDN for awhile. Are you aware of their conditional financing and VWAP requirement for said financing?

User Image vaselineguy Posted - 04/18/24

$ELDN what did I saaaayyy

User Image allRS Posted - 04/18/24

$ELDN how much is this gonna fly tmr??

User Image VrtcIl Posted - 04/18/24

Let's get that 3 on $ELDN. However, make sure to keep stop set and always protect your downside. Never blindly keep on holding, let the market dictate your decisions. Price: 2.09 Float: 21.2M Short Float: 0.5 % 💰 Dollar Volume: 3.1K ℹ️ USA | Biotechnology

User Image MoonShine007 Posted - 04/18/24

$ALLR wow all day red and green ah. $AGBA $ELDN

User Image VrtcIl Posted - 04/18/24

What are your targets on $ELDN? Closest round level at 2. Take out profits right before those round numbers. Many orders on those levels are waiting to get filled. Price: 2 Float: 21.2M Short Float: 0.5 % 💰 Dollar Volume: 25.0K ℹ️ USA | Biotechnology

User Image HScottMatusow Posted - 04/18/24

Alert = they're going to run $ELDN in short order here, and very high. #Biotech $XBI

User Image TipRanks Posted - 04/18/24

These 2 ‘Strong Buy’ Penny Stocks Are Poised for Over 300% Gains, Say Analysts https://www.tipranks.com/news/article/these-2-strong-buy-penny-stocks-are-poised-for-over-300-gains-say-analysts $ELDN $ABOS --

User Image MoonShine007 Posted - 04/10/24

$ELDN we’re green in low-volume.

User Image WagTwits Posted - 04/08/24

$ELDN

User Image Jadeite Posted - 04/08/24

$ELDN https://www.usatoday.com/story/news/health/2024/04/05/pig-kidney-transplant-rick-slayman/73214776007/ First pig kidney transplant patient is discharged from the hospital. Tegoprubart works, you know?

User Image WagTwits Posted - 1 month ago

$ELDN

User Image threethrees Posted - 1 month ago

$ELDN Does the company know bad this thing trades?

Analyst Ratings
HC Wainwright & Co. Buy Mar 22, 24
HC Wainwright & Co. Buy Nov 13, 23
HC Wainwright & Co. Buy Oct 24, 23
Noble Capital Markets Outperform Sep 27, 23
Cantor Fitzgerald Overweight Aug 22, 23
HC Wainwright & Co. Buy May 26, 23
SVB Leerink Outperform Jun 1, 22
HC Wainwright & Co. Buy Nov 24, 21
SVB Leerink Outperform Apr 27, 21